Indeed, treatment of recipient mice transplanted with CML stem cells with misoprostol, an agonist of the E-type proteinoid receptor-4 (EP4), has therapeutic effects [35]. This evidence concerns the gene PTGER4 and chronic myelogenous leukemia, BCR-ABL1 positive.